Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Acute Lung Injury (ALI) Associated With COVID-19”

2 trials

Showing 2 of 2 results

Testing effectiveness (Phase 2)Study completedNCT04402866
What this trial is testing

TD-0903 for ALI Associated With COVID-19

Who this might be right for
Acute Lung Injury (ALI) Associated With COVID-19Lung Inflammation Associated With COVID-19
Theravance Biopharma 235
Early research (Phase 1)Study completedNCT04350736
What this trial is testing

First in Human SAD and MAD Study of Inhaled TD-0903, a Potential Treatment for ALI Associated With COVID-19

Who this might be right for
Acute Lung Injury (ALI) Associated With COVID-19Inflammatory Lung Conditions Associated With COVID-19
Theravance Biopharma 54

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation